farmerparent4
About
Carboplatin plus etoposide vs . topotecan while second-line answer to patients along with delicate relapsed small-cell lung cancer: a good open-label, multicentre, randomised, period Three or more tryout.
Carboplatin plus etoposide vs . topotecan while second-line answer to patients along with delicate relapsed small-cell lung cancer: a good open-label, multicentre, randomised, period Three or more tryout.